Appointments: Crescendo, Shield, Sarepta, Verona, Hansa, Astellas and Pluristem
Executive Summary
This week’s roundup includes various high-level appointments by companies including Vencerx Therapeutics, which has elected a new CEO, Shield Therapeutics, Crescendo Biologics, Pluristem Therapeutics, Sarepta Therapeutics and Verona Pharma.